Drugs / AIDSVAX B/E
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT02771730 Background | Mar 2015 → Feb 2017 | — | Emergent BioSolutions | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AIDSVAX B/E | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02771730 ↗ |
| Modality | Vaccine | “an Oral HIV Vaccine” NCT02771730 ↗ |
| Route | Intramuscular | “administered intramuscularly (IM)” NCT02771730 ↗ |